Stryker has completed the previously announced acquisition of Inari Medical for a total equity value of nearly $4.9bn, marking a significant expansion into the venous thromboembolism (VTE ...

In January 2025, Stryker entered a definitive agreement to acquire all issued and outstanding shares of Inari Medical’s common stock. Credit: JHVEPhoto / Shutterstock. Stryker has completed the ...

Hiro Murai is one of the most exciting TV directors working today. Now he’s launching his own production to support and discover other visionary artists like himself. Today, Murai announced Chum ...

Stryker completed its acquisition of Inari Medical, the devicemaker said Feb. 19. The companies entered into a definitive agreement for the $4.9 billion acquisition in January. The deal will support ...

In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against other best performing healthcare stocks so far in 2025. Despite the ongoing craze surrounding ...

Despite the ongoing craze surrounding the GLP-1 obesity drugs, the healthcare sector was a lagger last year. On January 3, Jared Holz, Mizuho Securities America’s healthcare sector strategist ...

February 19, 2025—Stryker announced that it has completed the acquisition of Inari Medical, Inc., a provider of solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.

PETALING JAYA: Inari Amertron Bhd ’s share price tumbled nearly 6% to RM2.64 following Apple Inc’s plans to replace Broadcom Inc’s chips in its devices with homegrown components by early 2025.

PETALING JAYA: Near-term challenges due to lacklustre smartphone shipment will continue to weigh on Inari Amertron Bhd, whose core earnings at RM255mil for the nine-month period of financial year ...